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TUMOR necrosis factor-a (TNF-a ) plays an important
role in the pathogenesis of rheumatoid arthritis. The
present study was to evaluate the effects of lipopoly-
saccharide (LPS), phytomitogens and cytodifferentia-
tion  agents  on  cytotoxicity  of  TNF-a secreted  by
adherent  human  mononuclear  cells  (AMC).  TNF-a
cytotoxicity  in  LPS-treated,  phytomitogen-treated,
and  cytodifferentiation  agent-treated  AMC  superna-
tants were analyzed by the L929 bioassay system. Our
results showed that LPS could induce homogeneous
TNF-a production  by  AMC  whereas,  in  addition  to
TNF-a , phytomitogens could also induce other TNF-
like factors. Neither methotrexate, retinoic acid nor
sodium butyrate can inhibit TNF-a cytotoxicity, while
hexamethylene bisacetamide  could  not only  inhibit
TNF-a cytotoxicity but also TNF-a inducing ability of
LPS to AMC.
Key words: TNF-a , L929 bioassay, Adherent human mono-
nuclear cells
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune
disease  with  clinical  features  of  inflammation  and
destruction of joints. The pathogenic mechanism of
RA is still unknown. Several inflammatory mediators
and  cytokines  have  been  identified  in  the  synovial
fluid of RA patients.1 These mediators play important
roles in RA pathogenesis since they can induce the
release of tissue-damaging enzymes through cell–cell
interaction and  result  in  inflammation  and  destruc-
tion of joints.
Tumor necrosis factor-a (TNF-a ) is a pleiotrophic
cytokine secreted mainly by monocytes and macro-
phages.  TNF-a has  many  overlapping  bioactivities
with interleukin 1 (IL-1). Some of these bioactivities,
such as induction of synovial fibroblast proliferation,2
stimulation of fibroblasts and chondrocytes to secrete
prostaglandin E2 (PGE2) and collagenase,3 stimulation
of monocytes, endothelial cells and cultured rheuma-
toid synovial cells to produce IL-1,4 and activation of
polymorphic multinuclear leukocytes,5 were reported
to be associated with the inflammation, degeneration
and destruction of joints. TNF-a in synovial fluid of RA
patients  was  synthesized  by  synovial  tissue  and
correlated  with  their  seropositivity  of  TNF-a and
disease  activity.6 High  levels  of TNF-a mRNA  were
detected on rheumatoid synovial membrane.7 Accord-
ing to these observations,  TNF-a indeed plays a crucial
role in RA pathogenesis.
Non-steroid anti-inflammatory drugs, penicillamine,
azathioprine and cyclophosphamide are usually pre-
scribed  for  RA  treatment;  however,  these  effective
medications can lead to adverse side effects. Several
studies have demonstrated that a low dose of metho-
trexate  (MTX)  was  an  effective  medication  in  RA
intervention  with  very  limited  toxicity.8 The  anti-
inflammatory capacity of MTX was postulated to be
contributed to effective RA treatment. MTX can inhibit
not  only  the  synthesis  of  immunoglobulin
M-rheumatoid factor, but the regeneration of methio-
nine to block the synthesis of two important mediators
in cellular immune responses: S-adenosylmethionine
(SAM) and polyamine.9 However, the exact mechanism
of MTX to inhibit RA progress remained unclear. Segal
et al. has reported that MTX can inhibit neither the
synthesis nor secretion of IL-1 both in in vivo and in
vitro systems.10 Our  present  study  focused  on  the
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Mediators of Inflammation, 10, 199–208 (2001)elucidation of MTX effects on the cytotoxicity of TNF-a
secreted by  adherent  mononuclear  cells  (AMC).  In
addition, our study was the first to systemically analyze
and demonstrate the effect of various cytodifferentia-
tion agents that drive HL-60 cells differentiation, such
as  retinoic  acid  (Ra),  sodium  butyrate  (SB),  and
hexamethylene bisacetamide (HMBA), on the cytotox-
icity of TNF-a secreted by AMC.
The selection of a simple and rapid bioassay with
characteristics of high sensitivity and good reproduci-
bility is important for the analysis of TNF-a cytotox-
icity. According to the literature, the standard error of
the sample mean (SEM) in the standard L929 bioassay
system for TNF-a quantitation was reported to range
from  5  to  15%.  The  average  SEM  of  the  L929
cytotoxicity bioassay system established in the pres-
ent study could be reduced to be less than 5% (on
average, 2–3%) with our modification. Therefore, our
modified L929 bioassay system was rather consistent
and would be of benefit to the analysis or quantitation
of TNF-a cytotoxicity.
Materials and methods
AMC isolation
Peripheral  blood  mononuclear  cells  (PBMC)  were
isolated by Ficoll–Hypaque gradient centrifugation as
described previously. Briefly, 30ml of fresh peripheral
blood  was  gently  added  onto  the  top  of  24ml  of
Ficoll–Hypaque  solution. Buffy  coat was cautiously
collected after centrifugation at 450 ´ g for 30min at
20°C and washed three times with Hank’s balanced
salt solution (HBSS). Ten milliliters of PBMC (4 ´ 106
cells/ml)  was  incubated  at  37°C  for  1.5–2h  in  a
100mm  cell  culture  plate  and  washed  vigorously
(shaking  at  150  r.p.m.  for  2min)  three  times  with
HBSS. Ice-cold complete RPMI-1640 medium (RPMI-
1640  with  10%  fetal  bovine  serum,  2 mM  of
L-glutamine,  100U/ml  of penicillin  and 10 m g/ml  of
streptomycin) was added to the cell,  incubated for
30min  on  ice,  and AMC were  collected by  rubber
policeman. Cell density was adjusted to 5 ´ 105 cells/
ml using complete RPMI-1640 medium. Cell survival
rate and the percentage of AMC were determined as >
98% and > 94% by trypan blue exclusion test and non-
specific esterase stain, respectively.
AMC treatment
One milliliter of AMC (5 ´ 105 cells/ml) was cultured
in  each  well  of  a  24-well  tissue  culture  plate  and
incubated at 37°C for 1h. The medium was cautiously
discarded after the AMC had adhered to the culture
plate. TNF-a secretion of AMC cells was analyzed by
adding 1ml of RPMI-1640 containing various concen-
trations  of  phytomitogens  and  cytodifferentiation
agents,  respectively,  in  the  presence or  absence of
lipopolysaccharide (LPS) activation at 37°C (summa-
rized in Table 1). Culture medium was collected after
desired intervals, centrifuged at 500 ´ g for 5min at
4°C  and cell-free  supernatants were  aliquotted  and
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Table 1. TNF-like cytotoxicity in AMC supernatants stimulated by various agents
Inducing agents Absorbance
(570nm–650nm)
(mean 6 SEM)
TNF-like %
cytotoxicity
of L929 cells
Cytotoxic
activity
(U/ml)*
None (medium control) 654 ± 14.8 2.36 <1.0
LPS 0.02m g/ml 345 ± 14.8 73.50 55.6
PMA 200nM 503 ± 25.3 37.10 5.8
400nM 491 ± 33.5 39.86 6.1
PHA 5m g/ml 403 ± 22.6 60.14 17.2
10m g/ml 394 ± 18.7 62.22 20.5
PWM 2m g/ml 388 ± 10.4 63.59 22.8
5m g/ml 371 ± 7.2 67.51 28.3
ConA 5m g/ml 335 ± 9.8 75.80 58.3
10m g/ml 331 ± 3.5 76.72 61.1
MTX 0.5m g/ml 653 ± 11.3 2.53 <1.0
1.0m g/ml 646 ± 10.6 4.14 <1.0
2.0m g/ml 666 ± 21.9 0.46 <1.0
4.0m g/ml 647 ± 19.1 3.91 <1.2
Ra 1m M 628 ± 7.8 8.29 <1.2
5m M 627 ± 2.1 8.52 <1.2
SB 100m g/ml 637 ± 5.1 6.22 <1.1
250m g/ml 642 ± 11.2 5.06 <1.0
HMBA 5 mM 642 ± 3.5 5.06 <1.0
10 mM 637 ± 10.6 6.22 <1.0
*One unit was defined as the amount of TNF-a required to kill 50% of L929 target cells.stored at –80°C until use. The survival rate of adherent
cell  was determined to be >  95%  after the culture
medium  was  collected.  In  investigating  the  dose
effect of MTX and cytodifferentiation agents on the
TNF-a secretion by AMC, 5 ´ 105 cells/well of AMC
cells were incubated with 1ml  of LPS (0.02m g/ml)
containing RPMI-1640 with MTX (1ng/ml–1mg/ml),
Ra (0.5–80 m M)  or SB  (5–800 mM),  respectively,  at
37°C. For ruling out the possibility that there might
be  some mutual  interaction between MTX or cyto-
differentiation  agents  and  LPS,  LPS-containing
medium was removed after 1h of pulse and AMC was
washed three times with serum-free medium before
treatment  with  MTX  or  cytodifferentiation  agents.
Culture  supernatants  were  collected  and  stored  as
already described.
Cell culture
Murine L929 fibroblasts and human HEp-2 cells were
incubated in RPMI-1640 complete medium (RPMI-1640
with 10%  fetal  bovine serum,  2 mM of  L-glutamine,
100U/ml of penicillin and 100m g/ml of streptomycin)
and DMEM medium, respectively, at 37°C.
Evaluation of cellular susceptibility to
recombinant human TNF-a
Confluent monolayer murine  L929  fibroblasts  were
trypsinized and resuspended to 2 ´ 104 cells/ml with
RPMI-1640. One hundred microliters of cell suspen-
sion  was  seeded  to  each  well  of  a  96-well  tissue
culture plate. The medium was discarded after over-
night culture and replaced by RPMI-1640 containing
various concentrations of recombinant human TNF-a
(rhTNF-a )  and  1 m g/ml  of  actinomycin  D.  MTT
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl  tetrazolium
bromide, tetrazolium salt) assay was conducted after
16–20h of culture at 37°C. The sensitivity of HEp-2 to
rhTNF-a was analyzed using similar procedure with-
out actinomycin D exposure.
L929 cytotoxicity bioassay
L929  cytotoxicity  was  analyzed  by  modifying  the
methods form Baarsch et al.11 and Galloway et al.12
The  flowchart  of  our  modified  version  is  summa-
rized  in  Fig.  1.  Briefly,  2 ´ 104 cells/well  of  L929
cells in a 96-well tissue culture plate were overnight
cultured  at  37°C.  The  medium  was  replaced  by
100 m l  of  AMC  cell-free  supernatants  collected  as
already described. After L929 cells were exposed in
the  supernatants  for  20h,  20 m l  of  2.5ng/ml  MTT
was  added  into  each  well  of  AMC  supernatant-
treated L929  cells. After  4h of incubation  at  37°C,
the microplate was centrifuged at 500 ´ g, 4°C for
10min.  Then  the  supernatants  in  the  wells  were
carefully  discarded  and  100m l/well  of  dimethyl-
sulfoxide  (DMSO)  was  added  into  the  plate  to
dissolve  Formazan  crystals  for  10min.  The  absor-
bance  was  read and  recorded under  570nm,  with
reference  absorbance  under  650nm.  Results  were
represented as the absorbance at 570nm subtracted
from  that of  650nm  or  as  the  percentage of  L929
cytotoxicity.  The  percentage  of  L929  cytotoxicity
was calculated by following formula:
% cytotoxicity =
Absorbance of 100% viable
cell control wells –
absorbance of test wells
Absorbance of 100% viable
cell control wells
´ 100
The mean ± SEM of the percentage of L929 cytotox-
icity was calculated by data obtained from three to
eight wells.
L929 bioassay system for TNF-a quantitation
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FIG. 1. Flowchart of  the modified L929 cytotoxic  bioassay
system for TNF-a quantitation.Neutralization test
The neutralization test was conducted according to
Galloway  et  al.12 Briefly,  AMC  supernatants  were
diluted by RPMI–1640 and co-incubated with equal
volume of various concentration of TNF-a monoclonal
antibody solution containing 2 m g/ml actinomycin D
at room temperature for 2h. One hundred microliters
of the diluted supernatant was added to each well of
a 96-well tissue culture plate and the L929 cytotox-
icity test was conducted.
Statistical analysis
The statistical significance  of  the mean ± SEM was
analyzed by Student’s t-test.
Results
The present study focused on using a modified L929
cytotoxicity bioassay system for TNF-a quantitation to
analyze  the  effect  of  MTX  and  cytodifferentiation
agents, such as Ra, SB, and HMBA, on the cytotoxicity
of TNF-a secreted by AMC. In addition, the effect of
LPS,  4b -phorbol-12b -myristate-13a -acetate  (PMA),
phytohemagglutinin  (PHA),  pokeweed  mitogen
(PWM) and concanavalin A (ConA) on cytotoxicity of
TNF-a secreted by AMC were also investigated.
In  traditional  MTT  cytotoxicity  assay,  the  tetra-
zolium  salt  will  be  reduced  to  produce  Formazan
crystals by mitochondrial succinate dehydrogenase in
viable  cells. TNF-a cytotoxicity  could  be  indirectly
examined  by  enzyme-linked  immunosorbent  assay
reader after the Formazan crystals were completely
dissolved by solvents. Therefore, whether the crystals
could  be  completely  dissolved  would  significantly
affect the result of cytotoxicity test. Among various
solvents  reported  in  the  literature,  10%  sodium
dodecyl sulfate  (SDS)-0.01N HCl, 10%  SDS-50%  iso-
propanol,  20%  SDS-50%  dimethylformamide,  10%
SDS-50%  DMSO,  and  DMSO  alone  were  relatively
better  solvents  for  Formazan  crystal-dissolving  pur-
pose (Table 2). In terms of the incubation time and
mixing requirement, DMSO was the most convenient
solvent. Therefore,  we  chose  DMSO  as  the  crystal-
dissolving solution in our study.
HEp-2  and  L929  are  cell  lines  that  have  been
commonly used for the analysis of TNF-a cytotoxicity.
We  first  tested the  susceptibility  of  those two  cell
lines to rhTNF-a for establishing the bioassay system.
The 50% inhibition concentration (IC50) of TNF-a to
the  HEp-2  cell  was  determined  to  be  higher  than
10ng/ml (Fig.  2A),  while that of the L929 cell was
approximately  0.18ng/ml  (Fig.  2B).  Therefore,  we
chose L929 cells as target cells in our assay system
since L929 cells exhibited relatively high sensitivity to
TNF-a and  might  perform  better  precision  in  the
evaluation of TNF-a cytotoxicity.
AMC was cultured in complete RPMI-1640 medium
containing various agents respectively listed in Table
1. TNF-a cytotoxic activity of the AMC cell-free culture
supernatants under  the  exposure  of  various  agents
was analyzed by L929 bioassay system. The results are
summarized in Table 1. MTX and cytodifferentiation
agents  showed no  stimulatory  capacity on AMC to
produce TNF-a or TNF-like factors (< 10% of TNF-like
cytotoxicity  to  the  L929  cell).  Among  the  agents
tested in the study, ConA and PMA were relatively the
strongest and weakest that could induce the TNF-like
cytotoxicity, respectively.
Under  continuous  LPS  exposure,  AMC  could  be
immediately activated and the TNF-a cytotoxicity was
rapidly increased and reached a plateau within 10h.
Therefore, high TNF-a cytotoxicity could be detected
in  AMC  culture  supernatants  by  L929  cytotoxicity
assay (Fig. 3A). When AMC was temporarily pulsed by
LPS for only 1h, residual TNF-a cytotoxicity could be
consistently  detected  after  36h  of  LPS  removal;
however,  the  cytotoxicity  would  be  significantly
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Table 2. Comparison of dissolving capacity of various solvents to Formazan crystals
Solvent Formazan
crystal
solubility
Mixing Incubation
time
Dye-grain
and/or ppt
pH
Isopropanol + – 10min ++ 4
Methyl alcohol + – 10min + ND
Ethyl alcohol + – 10min + ND
1-Butanol ± – 30min ++ ND
2-Butanol ± – 30min +++ ND
Acid-isopropanol (0.04N HCl) + + 1–2h/16h ++/– 2–3
10% SDS in 0.01N HCl ++ – 1h/16h ±/– 3–4
10% SDS in 0.1N HCl +++* – 10min – 1–2
10% SDS-50% isopropanol ++ +/– 2h/16h – 6–7
20% SDS-50% dimethylformamide +++ +/– 1–2h/16h – 4–5
Mineral oil + – >16h – ND
10% SDS-50% DMSO +++ – 16h – 7–8
DMSO ++++ – <10min – 8–9
ppt, Precipitate. ND, Not determined.
*Formazan crystals were oxidized in strongly acidic solvent and turned yellow instead of purple.decreased  thereafter  (Fig.  3B).  For  identifying
whether  LPS  could  induce  AMC  to  secrete  other
factors  that exhibited TNF-like  cytotoxicity,  various
concentrations  of  anti-TNF-a monoclonal  antibody
(5–100ng/ml)  was  added  into  the  cell-free  super-
natants  to  neutralize  TNF-a cytotoxicity,  and  the
residual  TNF-like  cytotoxicity  of  the  AMC  super-
natant was subsequently analyzed. Fig. 4 shows that
the TNF-like cytotoxicity would be completely inhib-
ited  when  the  concentration  of  anti-TNF-a mono-
clonal  antibody  was  higher  than  20ng/ml.  The
results  demonstrated  that  TNF-like  cytotoxicity
induced by LPS was mainly contributed by homoge-
neous  TNF-a (Fig.  4  and  Table  3).  However,  in
addition to TNF-a , the TNF-like cytotoxicity induced
by  other mitogens,  such  as  PHA,  PMA, and  ConA,
seemed  to  be  caused  by  factors  other  than TNF-a
since  there  was  residual TNF-like  cytotoxic activity
after anti-TNF-a monoclonal antibody  neutralization
(Table 3).
We next analyzed the effect of MTX and cytodiffer-
entiation agents on cytotoxicity of TNF-a secreted by
LPS-activated  AMC.  AMC  were  activated  with
0.02 m g/ml  LPS  in  the  presence  of  MTX  at  various
concentrations (1ng/ml–1mg/ml), TNF-a cytotoxicity
of the culture supernatants was analyzed after over-
night  incubation.  Our  results  showed  that  MTX,
either in the condition of continuous (p > 0.1; Fig. 5A)
or  temporary  (p >  0.1;  Fig.  5B)  exposure,  had no
inhibitory capacity to cytotoxicity of TNF-a secreted
by AMC. The cytotoxicity of rhTNF-a activity would
neither  be  affected  when  rhTNF-a was  incubated
overnight with various concentration of  MTX (data
not shown). For ruling out the possibility that lack of
L929 bioassay system for TNF-a quantitation
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FIG. 2. (A) Dose–response curve of human HEp-2 cells in response to rhTNF-a . Various concentrations of rhTNF-a were diluted
with complete RPMI-1640 medium. Details are described in Materials and methods. Positive control wells containing 200ng/ml
of rhTNF-a were used as blank. The IC50 of rhTNF-a to HEp-2 cells was estimated to be more than 10ng/ml. (B) Dose–response
curve of murine L929 fibroblasts in response to rhTNF-a . Details of the L929 bioassay and MTT stain are described in Materials
and methods. The IC50 of rhTNF-a to L929 cells was estimated to be 0.18ng/ml.MTX inhibition to cytotoxicity of TNF-a secreted by
AMC was due to mutual physical or chemical inter-
action between LPS and MTX, TNF-a cytotoxicity in
the  supernatants was  analyzed  after AMC  was  first
pulsed with LPS for 1h and subsequently treated with
MTX  for  2  or  16h  after  LPS  removal. The  results
showed that MTX remained no inhibition capacity to
TNF-a cytotoxicity (Fig. 6A,B).
The  residual  mitogens  and  cytodifferentiation
agents in the AMC culture supernatants might cause
cytotoxic  effect  that  would  reinforce  the  TNF-a
cytotoxicity. Therefore,  we  further  investigated  the
L929 cytotoxicity caused by each agent for ruling out
this  possibility.  These  agents  were  proved  not  to
exhibit cytotoxicity to L929 cells under the concen-
tration  of  AMC  treatment  (<  0.5U/ml;  data  not
shown). The  cytotoxicity  of  rhTNF-a was  also  not
inhibited by those agents when we incubated L929
cells in the presence of each agent and rhTNF-a . In
addition,  1ng/ml  to  2m g/ml  of  anti-TNF-a mono-
clonal antibody had no L929 cytotoxicity either (data
not shown). Only high dosage of HMBA (> 40 mM)
showed  substantially  low  cytotoxicity  (1–1.5U/ml)
among cytodifferentiation agents (data not shown).
Fig. 7 demonstrates the results of the effect of Ra,
SB, and HMBA to cytotoxicity of TNF-a secreted by
AMC. The data showed that only HMBA (0.5–80 mM)
had significant inhibition capacity to cytotoxicity of
TNF-a secreted  by  LPS-activated AMC,  whereas  Ra
(0.5–80 m M) and SB (5–400 m g/ml) showed no inhibi-
tion (p > 0.05).
For ruling out the possibility of mutual interaction
between LPS and cytodifferentiation agents and fur-
ther investigating the correlation between cytodiffer-
entiation agents and TNF-a cytotoxicity, TNF-a activ-
ity was analyzed after AMC was first pulsed by LPS
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FIG. 3. (A) Time course of TNF cytotoxicity produced by AMC cultured in complete RPMI-1640 containing 0.02m g/ml of LPS.
Crude supernatants were harvested at the time indicated and TNF cytotoxicity in 10 ´ diluted cell-free supernatants was
analyzed. (B) Time course of TNF cytotoxicity produced by AMC activated under 1h of 0.02m g/ml LPS stimulation. Crude
supernatants were harvested at the time indicated and TNF cytotoxicity in 4 ´ diluted cell-free supernatants was assayed.for 1h and subsequently  incubated with cytodiffer-
entiation agents. Fig. 8 shows that only high concen-
trations of HMBA (> 10 mM) and SB (> 400m g/ml)
exhibited significant and slightly  inhibitory capacity
to  cytotoxicity  of TNF-a secreted  by  LPS-activated
AMC. Similar results were obtained when the HMBA
was  removed  after  overnight  incubation  with  LPS-
activated AMC to allow further TNF-a secretion (data
not shown).
Discussion
Many  cell  lines  have  been  used  in  the  analysis  of
TNF-a cytotoxicity. The IC50 of rhTNF-a (with  spe-
cific activity (2–4) ´ 108 U/ml) to ME-180, HeLa and
MRC-5 cells was approximately 1ng/ml, and that of
U937  cell  was  about  0.3mg/ml.12 A  simple TNF-a
bioassay was established using HEp-2 cells as target
cells;13 however, the IC50 of rhTNF-a to HEp-2 cells
was  detected  to  be  higher  than  10ng/ml  in  this
system (Fig. 2A). This result supported the observa-
tion that HEp-2 cells showed low sensitivity to TNF-
a . WEHI 1640 subclone 13 cells were reported to be
more sensitive to TNF-a than L929 cells, but the cell
density was too high and their sensitivity to TNF-a
would  be  decreased  or  even  turned  out  to  be
insensitive after multiple subcloning.14 The L929 cell
line  was  the  most  common  target  cell  for  the
detection of TNF-a cytotoxicity15 since the analysis
of TNF-a cytotoxicity to L929 would not be affected
by rhIL-1 and interferon-a . Therefore, we chose L929
as target cells  in  the analysis of TNF-a cytotoxicity.
The chemicals used in  our study  had no cytotoxic
effects to L929 and the IC50 of rhTNF-a to L929 cells
was only about 0.18ng/ml in  our study (Fig.  2B).
Conventional analytic methods for cellular growth/
proliferation  and  survival  included  calculation  of
L929 bioassay system for TNF-a quantitation
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FIG. 4. Neutralization curve of TNF-a cytotoxicity in LPS-stimulated AMC supernatants by anti-TNF-a monoclonal antibody.
TNF-a cytotoxicity in 10 ´ diluted AMC supernatants containing final concentrations of 5, 20, 50 or 100ng/ml anti-TNF-a
monoclonal antibody was assayed. Details are described in Materials and methods.
Table 3. Residual TNF-like cytotoxicity in AMC supernatants
with anti-TNF-a monoclonal antibody neutralization
Inducing agent Cytotoxicity
activity
(U/ml)
Residual cytotoxic
activity (U/ml)
remaining after
anti-TNF-a
neutralization
None (medium
control)
<1.0 <0.5
LPS 0.02m g/ml 55.6 <0.5
PMA 200nM 5.8 1.8
400nM 6.1 1.9
PHA 5m g/ml 17.2 4.1
10m g/ml 20.5 5.1
PWM 2m g/ml 22.8 <1.0
5m g/ml 28.3 <1.0
ConA 5m g/ml 58.3 1.6
10m g/ml 61.1 1.7
MTX 0.5m g/ml <1.0 <0.5
1.0m g/ml <1.0 <0.5
2.0m g/ml <1.0 <0.5
4.0m g/ml <1.0 <0.5
Ra 1m M <1.2 <0.5
5m M <1.2 <0.5
SB 100m g/ml <1.0 <0.5
250m g/ml <1.0 <0.5
HMBA 5 mM <1.0 <0.5
10 mM <1.0 <0.5staining  cells by  using  dyes  (such  as crystal  violet,
neutral red, etc.), measurement of  51Cr-labeled pro-
tein  released  by  lyzed  cells,  and  detection  of  the
incorporation  of  radioisotope-labeled  nucleic  acid
(such as [3H]-thymidine or [125I]-iododeoxyuridine).
The  MTT  colorimetric assay  has been  widely  used
since it was developed. The principle of MTT test was
the  reduction  of  tetrazolium  ring  to  dark-blue  For-
mazan  crystals  by  mitochondrial  succinate  dehy-
drogenase.16 Cell survival can be evaluated by measur-
ing the absorbance of Formazan crystals dissolved in
solution at 570nm. The number of survival cells and
the cytotoxicity of TNF-a is proportional and recipro-
cally correlated with the absorbance. The SEM of MTT
colorimetric assay of TNF-a cytotoxicity on L929 cells
was reported to be among 5–15%.15,17,18 But the SEM
of MTT test has been reduced to be less than 5% (on
average,  2–3%)  by  our modification.  Our  modifica-
tions of MTT assay were as following (Fig. 1). L929
cells were allowed to be pre-incubated overnight for
better stability. The initiative cell density was 2 ´ 104
cells/well in a 96-well  tissue culture plate, and this
would become approximately 95% confluence when
harvested. Control of cell number was an important
factor that could remain constant TNF-a sensitivity of
the  target  cells.  Besides,  the  removal  of  culture
medium before Formazan crystal dissolution by cen-
trifugation could be of benefit to both the prevention
of  a  pseudopositive  result  due  to  phenol  red  in
medium and a significant increase in the dissolution
of the Formazan crystal. The results from our modified
MTT assay had low SEM and high reproducibility. We
expected  that  this  modified  L929  bioassay  system
would be of great potential to be applied in clinical
analysis or quantitation of TNF-a cytotoxicity.
The effect of PMA, PHA and ConA to PBMC has
been  investigated,19 and  the  results  indicated  that
mitogen  was  a  relative  stronger  inducer  of  TNF-a
secretion  on  PBMC.  Our  study  investigated  the
induction ability of LPS and other mitogens, such as
PHA, PMA, ConA and PWM, on cytotoxicity of TNF-a
secreted by AMC. We  found  that LPS could induce
homologous TNF-a secretion; in addition, its induction
ability was higher than that of other mitogens (Table
2). The nature and characteristics of TNF-like factors
induced by mitogen-induced AMC await further study
to be elucidated.
MTX is an effective chemical in the RA intervention.
Nevertheless, its mechanism of action needed further
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FIG.  5.  Effect  of  MTX  on  TNF-a cytotoxicity.  AMC  were
activated  by  0.02m g/ml  LPS  in  the  presence  of  MTX  at
various  concentrations  (1ng/ml–1mg/ml).  After  overnight
culture, cell was washed to remove the LPS and MTX, and
then subsequently further incubated in the presence (A) or
absence (B) of MTX for 24h to allow TNF-a secretion. TNF
cytotoxicity in 10 ´ (A) or 5 ´ (B) diluted supernatants was
analyzed.
FIG. 6. Effect of MTX on cytotoxicity of TNF-a secreted by
LPS-pulsed AMC. After 1h of 0.02m g/ml of LPS stimulation,
AMC  were  washed  and  further  incubated  for  2h  (A)  or
overnight (B) in the presence of MTX at various concentra-
tions (10
–6 to 10
–2 mg/ml). TNF cytotoxicity in 10 ´ diluted
supernatants was analyzed.investigation. MTX exhibited anti-inflammatory activ-
ity8–10 such  as  inhibition  of  PMN  and  monocyte
chemotaxis,20 inhibition  of  B-cell  and  T-cell  func-
tion,21 and indirect inhibition of SAM and polyamine
formation  through  downregulation  of  dihydrofolate
reductase. Segal et al.10 demonstrated that MTX could
selectively inhibit IL-1 activity rather than its synthesis
and secretion. The present study examined the effect
L929 bioassay system for TNF-a quantitation
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FIG. 7. Effect of cytodifferentiation agents (HMBA, Ra and SB) on cytotoxicity of TNF-a secreted by AMC. AMC were activated
with 0.02m g/ml of LPS in the presence of cytodifferentiation agents at various concentrations (as summarized in Table 1). After
overnight culture, cell-free supernatants were harvested and TNF cytotoxicity in 10 ´ diluted supernatants was analyzed.
FIG. 8. Effect of cytodifferentiation agents on cytotoxicity of TNF-a secreted by LPS-pulsed AMC. After 1h of 0.02m g/ml LPS
stimulation, AMC  were washed and further incubated overnight in the presence of  cytodifferentiation agents at various
concentrations (as summarized in Table 1). TNF cytotoxicity in 5 ´ diluted supernatants was analyzed.of MTX or cytodifferentiation agents on the cytotox-
icity  of  TNF-a secreted  by  LPS-activated AMC.  We
found MTX (1ng/ml–1mg/ml) showed no inhibition
to TNF-a cytotoxicity (Figs. 5 and 6) whereas HMBA
exhibited significant inhibitory effect on cytotoxicity
of TNF-a secreted by LPS-activated AMC (Fig. 7). The
inhibition of HMBA to cytotoxicity of TNF-a secreted
by LPS-activated AMC might be due to the following
mechanisms. First of all, HMBA could kill AMC since
higher  concentrations  of  HMBA  exhibited  cytotox-
icity  to  L929  cells.  Second,  the  mutual  interaction
between HMBA and LPS could block AMC activation
by  LPS.  Third,  HMBA  could  indeed  inhibit  TNF-a
synthesis and secretion. Forth, HMBA can inhibit TNF-
a cytotoxicity  to  L929. The  first  possibility  can  be
ruled  out  by  the  trypan  blue  exclusion  test.  High
concentrations of HMBA (> 10 mM) indeed exhibited
an  inhibitory  effect  on TNF-a cytotoxicity  to  L929
(Figs. 7 and 8). HMBA also could partially block AMC
activation by LPS (Figs. 7 and 8). However, whether
the TNF-a sensitivity of L929 could be decreased by
HMBA awaits further study.
On  analysis  of  various  cytodifferentiation  agents
and  mitogens,  we  found  HMBA  showed  inhibitory
effect  of  TNF-a cytotoxicity  of  L929.  However,
whether HMBA could inhibit other biological effects
of  TNF-a ,  such  as  the  stimulation  of  fibroblast
proliferation, induction of PGE2 and collagenase, and
be a potential medication for RA treatment requires
further investigation. Besides, the activation of CD4+
T  cells  is  suggested  as  an  important  factor  in  RA
pathogenesis;22 therefore, it would be  intriguing  to
examine  whether  MTX  and  HMBA  could  regulate
other RA pathogenesis-related cytokines.
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